TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Accumulated Expenses (2019 - 2026)

TAO Synergies' (TAOX) quarterly Accumulated Expenses came in at $132444.0 in Q2 2026, up 100.36% on a YoY basis from $66104.0 in Q2 2025, and down 15.86% quarter-over-quarter from $157416.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Accumulated Expenses (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Accumulated Expenses for 8 consecutive years, with $132444.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses rose 100.36% year-over-year to $132444.0; the trailing twelve-month figure through Jun 2026 stood at $132444.0 (up 100.36% YoY), and the FY2025 full-year result was $638516.0, down 8.39% from the prior year.
  • Accumulated Expenses slipped to $132444.0 in Q2 2026 per TAOX's latest filing, from $157416.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $8.8 million in Q2 2024 and bottomed at $54542.0 in Q3 2024.
  • Historically, Accumulated Expenses has averaged $1.3 million across 5 years, with a median of $306551.5 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Accumulated Expenses jumped 12858.83% in 2024, then tumbled 99.25% in 2025.
  • Over 5 years, Accumulated Expenses stood at $536714.0 in 2022, then fell by 18.79% to $435891.0 in 2023, then surged by 59.9% to $696980.0 in 2024, then slipped by 8.39% to $638516.0 in 2025, then plunged by 79.26% to $132444.0 in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $132444.0, $157416.0, and $638516.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132,444.00
Mar 31, 2026 157,416.00
Dec 31, 2025 638,516.00
Sep 30, 2025 92,396.00
Jun 30, 2025 66,104.00
Mar 31, 2025 96,484.00
Dec 31, 2024 696,980.00
Sep 30, 2024 54,542.00
Jun 30, 2024 8.83 Mn
Mar 31, 2024 6.02 Mn
Dec 31, 2023 435,891.00
Sep 30, 2023 1.53 Mn
Jun 30, 2023 68,137.00
Mar 31, 2023 3.40 Mn
Dec 31, 2022 536,714.00
Sep 30, 2022 200,205.00
Jun 30, 2022 345,114.00
Mar 31, 2022 267,989.00
Dec 31, 2021 698,406.00
Sep 30, 2021 71,953.00